Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WEE1 | P30291 | 20/20 | 0.79 |
| ▸ | EGFR | P00533 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | PLK1 | P53350 | 1/20 | 0.79 |
| ▸ | MAP3K19 | Q56UN5 | 1/20 | 0.79 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.79 |
| ▸ | PLK2 | Q9NYY3 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27293934 | 0.96 | WEE1 (0.74) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL30817385 | 0.96 | WEE1 (0.73) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27293231 | 0.96 | WEE1 (0.73) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27293817 | 0.95 | WEE1 (0.72) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27291857 | 0.95 | WEE1 (0.73) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27291965 | 0.95 | WEE1 (0.76) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27291858 | 0.95 | WEE1 (0.70) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27293909 | 0.94 | WEE1 (0.70) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27293864 | 0.94 | WEE1 (0.70) | WEE1EGFRCYP3A4PLK1MAP3K19 | |
| SCHEMBL27291861 | 0.94 | WEE1 (0.72) | WEE1EGFRCYP3A4PLK1MAP3K19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024059808-A1 | WEE1 INHIBITORS AND METHODS FOR TREATING CANCER | RECURIUM IP HOLDINGS, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024059808-A1 | WEE1 INHIBITORS AND METHODS FOR TREATING CANCER | RECURIUM IP HOLDINGS, LLC (US) | 2024-03-21 | — | — | WO | disclosed |